LU84827A1 - Compositions pharmaceutiques contenant au moins un alcool polyfluore - Google Patents

Compositions pharmaceutiques contenant au moins un alcool polyfluore Download PDF

Info

Publication number: LU84827A1
Authority: LU; Luxembourg
Prior art keywords: composition according; formula; component; parts; polyfluorinated
Prior art date: 1982-05-28

Application number

LU84827A

Other languages

English (en)

French (fr)

Inventor

Emanuel Revici

Original Assignee

Fcn Srl

Alphatime Ltd Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-05-28

Filing date

1983-05-27

Publication date

1983-11-17

1983-05-27 Application filed by Fcn Srl, Alphatime Ltd Co Inc filed Critical Fcn Srl

1983-11-17 Publication of LU84827A1 publication Critical patent/LU84827A1/fr

Links

239000008194 pharmaceutical composition Substances 0.000 title claims description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title description 2
239000000203 mixture Substances 0.000 claims description 23
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 17
235000012000 cholesterol Nutrition 0.000 claims description 9
KUGBQWBWWNPMIT-UHFFFAOYSA-N 1,1,2,2,3,3,4,4-octafluoropentan-1-ol Chemical compound CC(F)(F)C(F)(F)C(F)(F)C(O)(F)F KUGBQWBWWNPMIT-UHFFFAOYSA-N 0.000 claims description 7
150000001298 alcohols Chemical class 0.000 claims description 7
239000008159 sesame oil Substances 0.000 claims description 5
235000011803 sesame oil Nutrition 0.000 claims description 5
239000004480 active ingredient Substances 0.000 claims description 3
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 2
239000002904 solvent Substances 0.000 claims 2
230000002485 urinary effect Effects 0.000 claims 2
230000000118 anti-neoplastic effect Effects 0.000 claims 1
125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims 1
229910052742 iron Inorganic materials 0.000 claims 1
241001465754 Metazoa Species 0.000 description 7
GUAMVMSOIYAUSK-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-hexadecafluorononan-1-ol Chemical compound CC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(O)(F)F GUAMVMSOIYAUSK-UHFFFAOYSA-N 0.000 description 5
230000001925 catabolic effect Effects 0.000 description 5
BYKNGMLDSIEFFG-UHFFFAOYSA-N 2,2,3,3,4,4,5,5,6,6,7,7-dodecafluoroheptan-1-ol Chemical compound OCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)F BYKNGMLDSIEFFG-UHFFFAOYSA-N 0.000 description 4
206010028980 Neoplasm Diseases 0.000 description 4
150000001875 compounds Chemical class 0.000 description 4
241000699670 Mus sp. Species 0.000 description 3
241000700159 Rattus Species 0.000 description 3
238000005303 weighing Methods 0.000 description 3
BBMCTIGTTCKYKF-UHFFFAOYSA-N 1-heptanol Chemical compound CCCCCCCO BBMCTIGTTCKYKF-UHFFFAOYSA-N 0.000 description 2
AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
206010070863 Toxicity to various agents Diseases 0.000 description 2
230000002159 abnormal effect Effects 0.000 description 2
230000001195 anabolic effect Effects 0.000 description 2
230000007665 chronic toxicity Effects 0.000 description 2
231100000160 chronic toxicity Toxicity 0.000 description 2
230000002349 favourable effect Effects 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
238000000034 method Methods 0.000 description 2
239000000243 solution Substances 0.000 description 2
231100000456 subacute toxicity Toxicity 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
241000699666 Mus <mouse, genus> Species 0.000 description 1
241000207961 Sesamum Species 0.000 description 1
235000003434 Sesamum indicum Nutrition 0.000 description 1
206010052428 Wound Diseases 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
230000007059 acute toxicity Effects 0.000 description 1
231100000403 acute toxicity Toxicity 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
238000000137 annealing Methods 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
230000037213 diet Effects 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
230000000694 effects Effects 0.000 description 1
239000012530 fluid Substances 0.000 description 1
235000013305 food Nutrition 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
239000010931 gold Substances 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
230000035876 healing Effects 0.000 description 1
230000003902 lesion Effects 0.000 description 1
230000003387 muscular Effects 0.000 description 1
230000017074 necrotic cell death Effects 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
231100000915 pathological change Toxicity 0.000 description 1
230000036285 pathological change Effects 0.000 description 1
230000001624 sedative effect Effects 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
239000003981 vehicle Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C31/34—Halogenated alcohols
- C07C31/38—Halogenated alcohols containing only fluorine as halogen

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

LU84827A 1982-05-28 1983-05-27 Compositions pharmaceutiques contenant au moins un alcool polyfluore LU84827A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT2155382		1982-05-28
IT8221553A IT8221553A0 (it)	1982-05-28	1982-05-28	Composizioni farmaceutiche adattivita' antineoplastica.

Publications (1)

Publication Number	Publication Date
LU84827A1 true LU84827A1 (fr)	1983-11-17

Family

ID=11183507

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU84827A LU84827A1 (fr)	1982-05-28	1983-05-27	Compositions pharmaceutiques contenant au moins un alcool polyfluore

Country Status (16)

Country	Link
JP (1)	JPS591414A ( )
AU (2)	AU552557B2 ( )
BE (1)	BE896838A ( )
CH (1)	CH653890A5 ( )
DE (1)	DE3319304A1 ( )
FR (1)	FR2527439A1 ( )
GB (1)	GB2121280B ( )
IE (1)	IE55137B1 ( )
IL (1)	IL68796A0 ( )
IN (1)	IN157042B ( )
IT (1)	IT8221553A0 ( )
LU (1)	LU84827A1 ( )
NL (1)	NL8301899A ( )
NZ (1)	NZ204393A ( )
SE (1)	SE8302976L ( )
ZA (1)	ZA833871B ( )

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3836971C1 ( ) *	1988-10-31	1990-05-17	Weck, Wolfgang, Dr.Med., 6990 Bad Mergentheim, De

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3219004C1 (de) *	1982-05-19	1984-03-01	Philippine Dr. 8000 München Hartmann	Arzneimittel zur Behandlung von Tumoren

1982
- 1982-05-28 IT IT8221553A patent/IT8221553A0/it unknown
1983
- 1983-05-20 CH CH2772/83A patent/CH653890A5/it not_active IP Right Cessation
- 1983-05-26 GB GB08314540A patent/GB2121280B/en not_active Expired
- 1983-05-26 JP JP58093889A patent/JPS591414A/ja active Pending
- 1983-05-26 AU AU15000/83A patent/AU552557B2/en not_active Expired - Fee Related
- 1983-05-26 BE BE2/60100A patent/BE896838A/nl not_active IP Right Cessation
- 1983-05-26 IL IL68796A patent/IL68796A0/xx unknown
- 1983-05-26 SE SE8302976A patent/SE8302976L/ not_active Application Discontinuation
- 1983-05-27 IN IN673/CAL/83A patent/IN157042B/en unknown
- 1983-05-27 IE IE1259/83A patent/IE55137B1/en unknown
- 1983-05-27 LU LU84827A patent/LU84827A1/fr unknown
- 1983-05-27 ZA ZA833871A patent/ZA833871B/xx unknown
- 1983-05-27 DE DE19833319304 patent/DE3319304A1/de not_active Ceased
- 1983-05-27 FR FR8308776A patent/FR2527439A1/fr not_active Withdrawn
- 1983-05-27 NL NL8301899A patent/NL8301899A/nl not_active Application Discontinuation
- 1983-05-27 NZ NZ204393A patent/NZ204393A/en unknown
1988
- 1988-05-04 AU AU15570/88A patent/AU1557088A/en not_active Abandoned

Also Published As

Publication number	Publication date
AU1557088A (en)	1988-11-10
NL8301899A (nl)	1983-12-16
ZA833871B (en)	1984-07-25
IN157042B ( )	1986-01-04
IE55137B1 (en)	1990-06-06
BE896838A (nl)	1983-09-16
GB8314540D0 (en)	1983-06-29
FR2527439A1 (fr)	1983-12-02
GB2121280B (en)	1985-08-29
SE8302976D0 (sv)	1983-05-26
SE8302976L (sv)	1983-11-29
GB2121280A (en)	1983-12-21
IE831259L (en)	1983-11-28
AU552557B2 (en)	1986-06-05
IT8221553A0 (it)	1982-05-28
JPS591414A (ja)	1984-01-06
IL68796A0 (en)	1983-09-30
DE3319304A1 (de)	1983-12-01
CH653890A5 (it)	1986-01-31
NZ204393A (en)	1986-03-14
AU1500083A (en)	1983-12-01

Publication	Publication Date	Title
CA2680433C (fr)	2014-08-12	Nouvelle composition a base d'oxime de cholest-4-en-3-one
CN102481324B (zh)	2014-06-18	调节脂质成分的组合物和方法
CH681692A5 ( )	1993-05-14
CA2330500A1 (fr)	1999-11-11	Compositions pharmaceutiques gelifiables
EP1248630A1 (fr)	2002-10-16	Composition, notamment cosmetique ou dermatologique, contenant des oligosaccharides, son procede de preparation et un procede de traitement cosmetique
BE895724A (fr)	1983-07-28	Nouvelle utilisation therapeutique de la dihydrocyclosporine d
FR2458285A1 (fr)	1981-01-02	Preparation pharmaceutique transdermique au dinitrate d'isosorbide
CA1106763A (fr)	1981-08-11	Compositions zootechiniques
LU84827A1 (fr)	1983-11-17	Compositions pharmaceutiques contenant au moins un alcool polyfluore
WO2004032967A1 (fr)	2004-04-22	Association entre un ligand des ppar et un agent antioxydant et utilisation dans le traitement de l'obesite
EP3242674A1 (fr)	2017-11-15	Compositions contenant de la curcumine à biodisponibilité améliorée
FR2771637A1 (fr)	1999-06-04	Utilisation d'un halogenure de dialkyldialkylammonium par voie parenterale dans les infections bacteriennes et virales
EP0155941A1 (fr)	1985-10-02	Composition de mineraux injectables a usage veterinaire
CA1059913A (fr)	1979-08-07	Compositions pharmaceutiques
El-Bahr et al.	2014	Hepatic gene expression of insulin like growth factor and selected antioxidants in diabetic rats treated with turmeric or black cumin seed
FR2520230A1 (fr)	1983-07-29	Preparations medicamenteuses contenant un derive d'acide tetraiodothyro-carboxylique notamment pour le traitement de l'hypercholesterolemie
EP0269598A1 (fr)	1988-06-01	Agents thérapeutiques contre la leishmaniose
FR2823M ( )	1964-11-06
CA1221635A (fr)	1987-05-12	Composition a activite pharmaceutique amelioree et utilisation de celle-ci pour des usages veterinaires
Patel et al.	1968	Toxicity and metabolism of 2-hydroxy-4-n-octoxybenzophenone
CA1166568A (fr)	1984-05-01	Compositions zootechniques renfermant d'une part, le zeranol et d'autre part, un steroide 4,9,11- trienique
FR2581311A1 (fr)	1986-11-07	Compositions pharmaceutiques pour le traitement de colites et colopathies, a base d'essence de thym et d'huile essentielle de cade
FI57209B (fi)	1980-03-31	Foerfarande foer stabilisering av en suspension av bariumsulfat i vatten
EP0635267A1 (fr)	1995-01-25	Compositions à base d'acides gras douées de propriétés anti-inflammatoires
WO2004014405A1 (fr)	2004-02-19	Utilisation d’extraits de ginkgo biloba pour favoriser la masse musculaire au detriment de la masse graisseuse